HEC-1-B Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Reproductive system cancer cell lines

Organism

Human

Donor History

Endometrial adenocarcinoma

Growth Properties

Adherent

Growth Conditions

Culture medium: EMEM (MEM Eagle)

,

w: 2 mM L-Glutamine

,

w: 2.2 g/L NaHCO3

,

w: EBSS (Cytion article number 820100a). Supplements: Supplement the medium with 10% FBS and 1% NEAA. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/HEC-1-B-Cells/305095

SKU: 305095 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The HEC-1-B cell line is a human endometrial adenocarcinoma cell line. This line has been utilized extensively in biomedical research related to the study of endometrial cancer, hormone responses, and cancer pharmacology. The cells are known to express estrogen and progesterone receptors, making them a valuable model for studying hormone-related dynamics in endometrial cancer progression and treatment. These cells have been used to investigate the molecular mechanisms of cancer cell proliferation, differentiation, and response to hormonal and chemotherapeutic treatments.

In terms of morphology, HEC-1-B cells typically exhibit an epithelial-like shape and grow in a monolayer. They are characterized by their high capacity for in vitro proliferation. Genetic studies have revealed several chromosomal alterations which are thought to contribute to the cancerous phenotype of these cells. Research using the HEC-1-B cell line has contributed to a deeper understanding of endometrial carcinogenesis and offers a robust system for testing potential therapeutic agents. This cell line is also commonly employed in studies focusing on cancer cell invasion and metastasis, providing insights into the cellular behaviors that underpin these processes.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.